JavaScript is disabled in your browser. Please enable JavaScript to view this website.

Limited use licenses

Broad Institute Limited License

Abcam provides its modified cell lines that have been generated using CRISPR Cas9 technology under a license agreement with the Broad Institute, Inc. ("Broad") that contains certain limitations and obligations. By purchasing such modified cell lines, you, (the “Buyer”), hereby agree to use the modified cell lines for your own internal research only, and in accordance with the Limited License below:

  1. the Buyer shall (a) not sell or otherwise transfer Products (including without limitation any material that contains a Product in whole or in part) to any other person or entity or (b) use Products to perform services for the benefit of any other person or entity except as otherwise permitted under license to Buyer from Broad or as otherwise permitted by Broad for non-profit use, as provided at https://www.broadinstitute.org/partnerships/office-strategic-alliances-and-partnering/information-about-licensing-crispr-genome-edi
  2. the Buyer shall use only the purchased amount of the Products purchased from Company, and shall use Products and components of the Products only for its internal research within the Field, which may include internal research within the Field in connection with product research, but not for the production, manufacture or exploitation of any product or Product or any Commercial Purposes
  3. the Buyer shall use Products in compliance with all applicable laws and regulations, including without limitation applicable human health and animal welfare laws and regulations
  4. the Licensor Parties shall provide no warranties of any kind to the Buyer (statutory or implied) concerning the Patent Rights or Products, including without limitation, as to product quality, condition, description, merchantability, fitness for a particular purpose, non-infringement of intellectual property rights or the absence of latent or other defects, and all such warranties are hereby expressly disclaimed
  5. the Licensor Parties shall expressly disclaim any warranty regarding results obtained through the use of the Products, including without limitation any claim of inaccurate, invalid or incomplete results
  6. the Licensor Parties and their directors, trustees, officers, employees, agents, faculty, affiliated investigators, and students, shall have no liability to the Buyer, including, without limitation, for any loss of use or profits, business interruption or any consequential, incidental, special or other indirect damages of any kind, regardless of how caused and regardless of whether an action in contract, tort, strict product liability or otherwise
  7. the Buyer shall indemnify, defend and hold harmless the Indemnitees against any liability, incurred by or imposed upon any of the Indemnitees, as applicable, in connection with any claims, suits, investigations, actions, demands or judgments arising out of or related to the exercise of any rights granted to the Buyer under the Limited License or any breach of the Limited License by such Buyer, provided that, to the extent the foregoing is not permitted by law, the Buyer agrees, to the extent permitted by law, that it, and not the Indemnitees, as applicable, shall be responsible for any liability, damage, loss or expense arising out of or related to the exercise of any rights granted to the Buyer under the Limited License or any breach of the Limited License by Buyer
  8. the Product and its use may be the subject of one or more issued patents or pending patent applications owned by one or more Licensor Parties and the purchase of the Product does not convey a license under any claims in the foregoing patents or patent applications directed to the Product or use, production or commercialization thereof, except as expressly set forth in the Limited License
  9. this Limited License does not contain any restrictions on the use of Products by non-profit institutions other than those set forth in the foregoing clauses (1) – (8), including without limitation, any reach-through rights (including without limitation any right to receive payment) with respect to products or discoveries made, discovered, derived, identified or selected using such Products.
  10. nothing in this Limited License shall be construed to confer any rights upon Buyer by implication, estoppel, or otherwise as to any technology or patent rights of any entity other than the Patent Rights. In addition, nothing in this Limited License shall be construed to confer upon Buyer or any Third Party any rights under or to the Patent Rights outside of the Field.

The following definitions apply to the Limited License:

Commercial Purposes means (a) the practice, performance or provision of any method, process or service, or (b) the manufacture, production, sale, use, distribution, disposition or importing of any product, in each case (a) or (b) for consideration of any kind, for the purpose of sale or commercial exploitation, or on any other commercial basis.

Company means Abcam Ltd

-.

Enabled Product means any product, that is not the Licensed Product, which is or incorporates (a) any progeny, modification or derivative of the Licensed Product, or (b) any cell, organism or animal made or modified through use of the Licensed Product, or any progeny, modification or derivative of such cell, organism or animal. For clarity, any product that is made, produced or derived by use of the technology of the Patent Rights, such as a protein or a peptide from a cell line shall be deemed an Enabled Product; provided, however, that the term Enabled Product shall not include any large or small molecule that(i) was identified or discovered through screening using technology covered by the Patent Rights and (ii) does not otherwise fall within the foregoing clauses (a) through (b).

Field means use as a research tool for research purposes; provided, however, that notwithstanding the foregoing, the Field shall expressly exclude (a) any clinical use, including, without limitation, diagnostic and prognostic use,(b) any human, veterinary, livestock or agricultural use, or (c) the manufacture, distribution, importation, exportation, transportation, sale, offer for sale, marketing, promotion or other exploitation or use of, or as, a testing service, therapeutic or diagnostic for humans or animals.

Indemnitees means each Licensor Party, their affiliates, and their current and former trustees, directors, officers, faculty, affiliated investigators, students, employees, medical and professional staff and agents and their respective successors, heirs and assigns

Licensed Patent Rights means (a) any patents and patent applications listed in the Broad Institute Patent Rights table below; (b) any substitutions, divisions, continuations, reissues, renewals, re-examinations or extensions of any patents or patent applications of (a), any continuations-in-part of any patents or patent applications of (a) to the extent the claims are directed to subject matter specifically described in a patent or patent application set forth on Appendix A, and any application claiming priority to a provisional application listed in the Broad Institute Patent Rights table below, to the extent the claims are directed to subject matter specifically described in a provisional patent application set forth on Appendix A; (c) any letters patents and/or the equivalent issuing therefrom in any jurisdiction based on any of the foregoing; and (d) any foreign or international equivalents of any of the foregoing, including without limitation any applications filed under the Patent Cooperation Treaty.

Licensor Parties means the Broad Institute, Inc.; the President and Fellows of Harvard College, Massachusetts Institute of Technology, University of Iowa Research Foundation; University of Tokyo; Rockefeller University; New York University, New York Genome Center.

Product means any product (a) that is Covered by at least one Claim of the Patent Rights or (b) that is not described in the foregoing clause (a) but that includes, uses, is derived from or is developed, identified or made through the use of technology Covered by at least one Claim of the Patent Rights or a product covered by the foregoing clause (a) (including any biological material, cell, organism or animal so derived, developed, identified or made) and any progeny, modifications, improvements or derivatives thereof; provided, however, that the term “Product” shall not include (A) any therapeutic large or small molecule that (i) was identified through screening using the technology Covered by the Patent Rights and (ii) does not otherwise make use of the Patent Rights or (B) any product that would not otherwise be a Product except for the use of a Product, Process or the technology Covered by at least one Claim of the Patent Rights solely for purposes of Company’s internal quality control or validation.

Broad Institute Patent Rights

EXEMPLARY FAMILY SERIAL NO
PATENT TITLE
PCT/US2013/074611
CRISPR-CAS Component Systems, thods and Compositions for Sequence Manipulation
PCT/US2013/074743
CRISPR-CAS Systems and Methods for Altering Expressions of Gene Products
14/259,420
CRISPR-CAS Systems, Methods and Compositions For Sequence Manipulation in Eukaryotes
PCT/US2013/051418
Inducible DNA Binding Proteins and Genome Perturbation Tools and Applications Thereof
PCT/US2013/074825
Methods, Systems and Apparatus for Identifying Target Seuqences for CAS Enzymes or CRISPR-CAS Systems for Target Sequences and Conveying Results Thereof
PCT/US2013/074812
Methods, Models, Systems and Apparatus for Identifying Target Sequences for CAS Enzymes or CRISPR-CAS Systems for Target Sequences and Conveying Results Thereof
PCT/US2013/074667
Delivery, Engineering and Optimization of Systems Methods and Compositions for Sequence Manipulation and Therapeutic Applications
PCT/US2014/041803
Delivery, Engineering and Optimization of Systems, Methods and Compositions for Sequence Manipulation and Applications
PCT/US2013/074691
Engineering and Optimization of Improved Systems, Methods and Enzyme Compositions for Sequence Manipulation
PCT/US2013/074736
Engineering and Optimization of Systems, Methods and Compositions for Sequence Manipulation with Functional Domains
PCT/US2013/074819
Engineering of Systems, Methods and Optimized Guide Compositions for Sequence Manipulation
14/855,046
Recombinant Virus And Preparations Thereof
PCT/US2014/041800
Delivery, Engineering and Optimization of Tandem Guide Systems, Methods and Compositions for Sequence Manipulation
PCT/US2014/041806
Fiunctional Genomics Using CRISPR-Cas Systems, Compositions, Methods, Screens and Applications Thereof
PCT/US2014/064663
CRISPR-Related Methods and Compositions with Governing gRNAS
PCT/US2014/069902
Compositions and Methods of Use of CRISPR-Cas Systems in Nucleotide Repeat Disorders
PCT/US2014/069897
Compositions and Methosd of Use of CRISPR-CAS Systems in Nucleotide Repeat Disorders
15/171,141
CRISPR-CAS Systems, Crystal Structure and Uses Thereof
15/349,603
Delivery, Engineering and Optimization of Systems, Methods and Compositions for Sequence Manipulation and Therapeutic Applications
15/467,949
Use and Production of CHD8+/- Transgenic Animals with Behavioral Phenotypes Characteristic of Autism Spectrum Disorder
15/469,081
Functional Screening with Optimized Functional CRISPR-Cas Systems
PCT/US2015/067177
CRISPR Having or Associated with Destabilization Domains
PCT/US2015/065385
Protected Guide RNAs (PGRNAs)
15/632,067
RNA-Targeting System
PCT/US2015/067138
Unbiased Identification of Double- Strand Breaks and Genomic Rearrangement by Genome-Wide Insert Capture Sequencing
PCT/US2015/065393
Dead Guides for CRISPR Transcription Factors
15/619,735
Escorted and Functionalized Guides for CRISPR-CAS Systems
15/619,737
Delivery, Use and Therapeutic Applications of CRISPR Systems and Compositions for Genome Editing as to Hematopoietic Stem Cells (HSCs)
15/640,103
CRISPR MEDIATED IN VIVO MODELING AND GENETIC SCREENING OF TUMOR GROWTH AND METASTASIS
PCT/US2016/038252
Engineering and Optimization of Systems, Methods, Enzymes and Guide Scaffolds of CAS9 Orthologs and Variants for Sequence Manipulation
PCT/US2016/038034
CRISPR Enzyme Mutations Reducing Off-Target Effects
PCT/US2016/038205
CRISPR Mediated Recording of Cellular Events
PCT/US2017/047458
Novel CRISPR Enzymes and Systems
PCT/US2017/053795
Systematic Screening and Mapping of Regulatory Elements in Non-Coding Genomic Regions, Methods, Compositions, and Applications Thereof
62/502,064 62/564,102
Methods for Identification and Modification of LNCRNA Associated with Target Genotypes and Phenotypes
62/529,573
Methods for Designing Guides Sequences for Guided Nucleases
PCT/US2014/070068
CRISPR-CAS Systems and Methods for Altering Expression of Gene Products, Structural Information and Inducible Modular CAS Enzymes
PCT/US2014/041804
DELIVERY AND USE OF THE CRISPR- CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
PCT/US2014/070127
Delivery, Use and Therapeutic Applications of the CRISPR-Cas Systems and Compositions for Genomic Editing
PCT/US2014/041808
Delivery, Engineering and Optimization of Systems, Methods and Compositions for Targeting and Modeling Diseases and Disorders of Post Mitotic Cells
PCT/US2014/041809
Delivery, Use and therapeutic Applications of the CRISPR-Cas systems and Compositions for Targeting Disorders and Diseases Using Viral Components
PCT/US2014/070057
Delivery, Use and Therapeutic Applications of the CRISPR-CAS Systems and Compositions for Targeting Disorders and Diseases Using NanoParticle Components
PCT/US2013/074800
Functional Genomics Using CRISPR- CAS Systems, Compositions, Methods, Knock Out Libraries and Applications Thereof
PCT/US2014/070152
Engineering Of Systems, Methods And Optimized Guide Compositions with New Architectures For Sequence Manipulation
PCT/US2014/070175
Systems, Methods and Compositions for Sequence Manipulation with Optimized Functional CRISPR-CAS Systems
PCT/US2015/045504
Genome Editing Using CAS9 Nickases
15/467,888
Delivery, Use and Therapeutic Applications of the CRISPR-CAS Systems and Compositions for Modeling Competition of Multiple Cancer Mutations in Vivo

ERS Genomics Terms of Use

Abcam provides its modified cell lines that have been generated using CRISPR Cas9 technology under a license agreement with the ERS Genomics Limited ("ERS") that contains certain limitations and obligations. By purchasing such modified cell lines, you, the buyer, hereby agree to use the modified cell lines for your own internal research only, and in accordance with the Terms of Use set out below:

BEFORE PLACING AN ORDER OR USING THIS PRODUCT, PLEASE READ THE TERMS AND CONDITIONS SET FORTH BELOW. YOUR PURCHASE OF THIS PRODUCT SHALL CONSTITUTE ACKNOWLEDGMENT AND ACCEPTANCE OF THESE TERMS AND CONDITIONS.

Certain commercial entities and/or activities performed at commercial entities may require additional contract rights from ERS Genomics Limited which are not granted through the purchase of this product. For additional information please see www.ersgenomics.com/research-products.php.

The buyer receives a non-exclusive, non-transferable right to use the Product, Progeny (meaning any unmodified descendant form of the Product), Modifications (meaning any modifications of the Product) and Unmodified Derivatives (meaning any substances created by the buyer which constitute an unmodified functional subunit or product expressed by the Product) for RESEARCH USE ONLY, which, subject to the exclusions below, includes use to discover and develop any product, including therapeutic products, which may then be sold to third parties, provided, however, that such products do not incorporate the Product, Progeny, Modifications, or Unmodified Derivatives.

No “Commercial Use” is allowed. Commercial Use means any and all uses of the Product, Progeny, Modifications or Unmodified Derivatives thereof, or any modified cells or organisms created through use of the foregoing, including but not limited to:

(1) Sale, whether or not such sale is limited for use in research;

(2) Provision of a service to a third party;

(3) Use in any diagnostic, preventative, or therapeutic application;

(4) Use in any veterinary, livestock or agricultural application;

(5) Use in later stage development of therapeutics, diagnostics, prophylactics (e.g., hit-to-lead, lead optimization); and

​(6) Manufacturing of a product for sale.

For clarity, transfer of materials or provision of services by not for profit or academic core labs to their internal clients shall not constitute a Commercial Use.

Except for the rights granted herein, any and all rights to the Product, Progeny, Modifications or Unmodified Derivatives thereof, shall remain in Abcam. No ownership rights are transferred.

The buyer shall have no right to assign the rights granted herein to third parties. The Product, Progeny, Modifications or Unmodified Derivatives thereof, must at all times remain in the possession of the buyer, except for a transfer to a scientific collaborator or to a service provider, to perform services, solely on behalf of the buyer.

ERS Genomics Limited is an intended third-party beneficiary under these Terms of Use.

ERS Genomics Limited Patent Rights (July 2019)

Granted Patents

Country
Application No.
Filing Date
Patent No.
Grant Date
AU
2013266968
15 Mar 2013
AU 2013266968 B2
07 Dec 2017
CN
201380038920.6
15 Mar 2013
CN 104854241 B
14 Jul 2017
EP
13793997.1
15 Mar 2013
EP 2800811 B1
10 May 2017
EP
17163434.8
15 Mar 2013
EP 3241902 B1
28 Feb 2018
EP
18152360.6
15 Mar 2013
EP 3401400 B1
03 Apr 2019
GB
1420270.9
15 Mar 2013
GB 2518764 C
02 Mar 2016
GB
1601071.2
15 Mar 2013
GB 2537000 B
08 Mar 2017
HK
15106335.4
03 Jul 2015
HK 1207107 B
25 Aug 2017
HK
15112610.8
23 Dec 2015
HK 1211978 B
04 May 2018
HK
17103002.1
03 Jul 2015
HK 1230233 B
01 Jun 2018
JP
20150514015
15 Mar 2013
JP 6343605 B
25 May 2018
MX
20140014477
15 Mar 2013
MX 349744 B
10 Aug 2017
NZ
714353
15 Mar 2013
NZ 714353 B2
29 Aug 2017
SG
11201407702
15 Mar 2013
SG 11201407702X
20 Mar 2017
SG
10201701800Y
15 Mar 2013
SG 10201701800Y
21 Nov 2018
TN
2014/0493
25 Nov 2014
TN 24223
03 Jun 2016
UA
A201413835
15 Mar 2013
UA 118014
12 Nov 2018
US
13/842,859
15 Mar 2013
US 10266850 B2
23 Apr 2019
US
14/685,502
13 Apr 2015
US 10000772 B2
19 Jun 2018
US
14/942,782
16 Nov 2015
US 10227611 B2
12 Mar 2019
US
15/138,604
26 Apr 2016
US 10113167 B2
30 Oct 2018
ZA
2014/07881
29 Oct 2014
ZA 2014/07881
31 Jan 2018
DE
2020132012240.4
15 Mar 2013
DE 202013012240 U1
02 Feb 2016
DE
2020132012241.2
15 Mar 2013
DE 202013012241 U1
18 Jan 2016
DE
2020132012242.0
15 Mar 2013
DE 202013012242 U1
02 Feb 2016

Patent Applications

Country
Application No.
Filing Date
Publication No.
Publication Date
PCT
PCT/US2013/032589
15 Mar 2013
WO 2013/176772 A1
28 Nov 2013
AE
P1296/2014
25 Nov 2014
AU
2017225060
07 Sep 2017
AU 2017225060 A1
28 Sep 2017
AU
2019201850
18 Mar 2019
BR
1120140294410
15 Mar 2013
BR 1120140294410 A2
27 Jun 2017
CA
2872241
15 Mar 2013
CA 2872241 A1
28 Nov 2013
CL
2014003208
25 Nov 2014
CL 2014003208 A1
19 Jun 2015
CN
201710585690.5
15 Mar 2013
CN 107603976 A
19 Jan 2018
CO
20140259531
25 Nov 2014
CO 7151523 A2
29 Dec 2014
CR
20140538
24 Nov 2014
CR 20140538 A
18 Feb 2015
DZ
140780
22 Dec 2014
EA
201401319
15 Mar 2013
EA 201401319 A1
29 May 2015
EC
IEPI-2014-28704
15 Mar 2013
30 Oct 2015
EG
PCT1887/2014
15 Mar 2013
EP
19157590.1
15 Mar 2013
GB
1511669.2
15 Mar 2013
GB 201511669 D0
19 Aug 2015
GE
AP2013013674
15 Mar 2013
HK
15104473.1
12 May 2015
HK 1204003 A1
06 Nov 2015
HK
19119875.3
22 Feb 2019
ID
P00201407783
10 Dec 2014
2016/03367
13 May 2016
IL
235461
15 Mar 2013
31 Dec 2014
IL
261563
15 Mar 2013
31 Oct 2018
IL
261565
15 Mar 2013
31 Oct 2018
IL
261566
15 Mar 2013
31 Oct 2018
IL
261567
15 Mar 2013
31 Oct 2018
IL
261568
15 Mar 2013
31 Oct 2018
IL
261569
15 Mar 2013
31 Oct 2018
IL
261570
15 Mar 2013
31 Oct 2018
IN
2995/KOLNP/2014
15 Mar 2013
2995/KOLNP/2014 A
04 Dec 2015
JP
2018-097369
21 May 2018
2018-138054
06 Sep 2018
KE
P/2014/002178
25 Nov 2014
KR
1020147036096
15 Mar 2013
KR 1020150016588 A
12 Feb 2015
KR
1020177034069
15 Mar 2013
KR 1020170134766 A
06 Dec 2017
KS
P/2017/000022
15 Mar 2013
LY
4958/2014
15 Mar 2013
MA
37663
15 Mar 2013
MA 37663 A1
31 May 2017
MX
2017010309
15 Mar 2013
MX
2019001995
15 Mar 2013
MY
PI2014003102
15 Mar 2013
MY
PI2018700285
15 Mar 2013
NZ
701326
15 Mar 2013
NZ
728024
15 Mar 2013
NZ 728024 A
27 Jan 2017
NZ
730667
15 Mar 2013
NZ 730667 A1
31 Mar 2017
OM
P/2014/00268
25 Nov 2014
PA
90441-01
25 Nov 2014
12 Sep 2016
PE
002211-2014/DIN
15 Mar 2013
PE 03362015 A1
25 Mar 2015
PH
12014502574
19 Nov 2014
PH 12014502574 A1
21 Jan 2015
QA
20141100400
15 Mar 2013
SG
10201809817U
15 Mar 2013
SG 10201809817U A
28 Dec 2018
SY
2014120156
15 Mar 2013
TH
1401007063
15 Mar 2013
TH 173084
15 Feb 2018
UA
A201808549
07 Aug 2018
US
61/652,086
25 May 2012
US
61/716,256
19 Oct 2012
US
61/757,640
28 Jan 2013
US
61/765,576
15 Feb 2013
US
14/403,475
24 Nov 2014
US 2016/0046961 A1
18 Feb 2016
US
14/685,504
13 Apr 2015
US 2016/0130609 A1
12 May 2016
US
14/685,513
13 Apr 2015
US 2016/0060653 A1
03 Mar 2016
US
14/685,514
13 Apr 2015
US 2016/0060654 A1
03 Mar 2016
US
14/685,516
13 Apr 2015
US 2016/0068864 A1
10 Mar 2016
US
15/090,511
04 Apr 2016
US 2017/0051312 A1
23 Feb 2017
US
15/343,156
03 Nov 2016
US
15/343,158
03 Nov 2016
US
15/435,233
16 Feb 2017
US 2017/0166893 A1
15 Jun 2017
US
15/803,424
03 Nov 2017
US 2018/0282764 A1
04 Oct 2018
US
15/915,020
07 Mar 2018
US 2019/0062790 A1
28 Feb 2019
US
15/925,544
19 Mar 2018
US 2018/0208931 A1
26 Jul 2018
US
15/947,680
06 Apr 2018
US 2018/0230495 A1
16 Aug 2018
US
15/947,700
06 Apr 2018
US 2018/0230496 A1
16 Aug 2018
US
15/947,718
06 Apr 2018
US 2018/0230497 A1
16 Aug 2018
US
15/959,715
23 Apr 2018
US 2018/0298406 A1
18 Oct 2018
US
15/959,735
23 Apr 2018
US 2018/0298407 A1
18 Oct 2018
US
15/959,762
23 Apr 2018
US 2018/0237801 A1
23 Aug 2018
US
15/959,782
23 Apr 2018
US 2018/0245100 A1
30 Aug 2018
US
15/959,802
23 Apr 2018
US 2018/0273981 A1
27 Sep 2018
US
15/965,598
27 Apr 2018
US 2018/0245101 A1
30 Aug 2018
US
15/965,603
27 Apr 2018
US 2018/0251791 A1
06 Sep 2018
US
15/981,807
16 May 2018
US 2018/0251793 A1
06 Sep 2018
US
15/981,808
16 May 2018
US 2018/0251794 A1
06 Sep 2018
US
15/981,809
16 May 2018
US 2018/0251795 A1
06 Sep 2018
US
16/033,002
11 Jul 2018
US 2018/0312874 A1
01 Nov 2018
US
16/033,005
11 Jul 2018
US 2018/0312875 A1
01 Nov 2018
US
16/033,016
11 Jul 2018
US 2018/0312876 A1
01 Nov 2018
US
16/136,159
19 Sep 2018
US 2019/0002921 A1
03 Jan 2019
US
16/136,165
19 Sep 2018
US 2019/0002922 A1
03 Jan 2019
US
16/136,168
19 Sep 2018
US 2019/0002923 A1
03 Jan 2019
US
16/136,175
19 Sep 2018
US 2019/0010520 A1
10 Jan 2019
US
16/201,836
27 Nov 2018
US 2019/0093129 A1
28 Mar 2019
US
16/201,848
27 Nov 2018
US 2019/0106711 A1
11 Apr 2019
US
16/201,853
27 Nov 2018
US 2019/0106712 A1
11 Apr 2019
US
16/201,855
27 Nov 2018
US 2019/0106713 A1
11 Apr 2019
US
16/201,862
27 Nov 2018
US 2019/0106714 A1
11 Apr 2019
US
16/201,865
27 Nov 2018
US 2019/0106715 A1
11 Apr 2019
US
16/276,343
14 Feb 2019
US
16/276,348
14 Feb 2019
US
16/276,352
14 Feb 2019
US
16/276,356
14 Feb 2019
US
16/276,361
14 Feb 2019
US
16/276,365
14 Feb 2019
US
16/276,368
14 Feb 2019
US
16/276,374
14 Feb 2019
US
16/277,090
15 Feb 2019
US
16/380,758
10 Apr 2019
US
16/380,781
10 Apr 2019
US
16/382,093
11 Apr 2019
US
16/382,096
11 Apr 2019
US
16/382,097
11 Apr 2019
US
16/382,100
11 Apr 2019
US
16/383,412
12 Apr 2019
US
16/383,422
12 Apr 2019
US
16/383,433
12 Apr 2019
US
16/383,443
12 Apr 2019
US
16/385,360
16 Apr 2019
US
16/385,383
16 Apr 2019
UZ
IAP20140559
15 Mar 2013
VN
1-2014-04335
15 Mar 2013
ZA
2017/00720
30 Jan 2017

Sigma-Aldrich CRISPR Use License Agreement

Abcam provides its modified cell lines that have been generated using CRISPR technology under a license agreement with Sigma-Aldrich Co. LLC. (“Sigma”) that contains certain limitations and obligations. By purchasing such modified cell lines, you, (the “Buyer”), hereby agree to use the modified cell lines for your own internal research only, and in accordance with the CRISPR Use License Agreement (“License Agreement”) set out below:

This Product and its use are the subject of one or more of the following patents and applications controlled by Sigma: Patent applications and issued patents that entered their respective National Stage from PCT International Pub. No. WO 2014/089290, including, but not limited to, the following, and substitutions, divisions, continuations, continuations-in-part, reissues, reexaminations, and extensions thereof: Australia Patent Nos. 2013355214; 2017204031; and 2018229489; Canada Patent No. 2,891,347; China Patent No. CN105142669; European Patent Nos. EP 3 138 910 B1, 3 138 911 B1, and EP 3 138 912 B1; Israel Patent No. IL238856; Singapore Patent No. 11201503824S; South Korea Patent No. 10- 1844123; and U.S. Patent Application Serial Nos. 15/188,911; 15/188,924; 15/188,927; 15/188,931; and 15/456,204 (the “Patent Rights”).

BEFORE OPENING OR USING THIS PRODUCT, PLEASE READ THE TERMS AND CONDITIONS SET FORTH IN THIS LICENSE AGREEMENT. YOUR USE OF THIS PRODUCT SHALL CONSTITUTE ACKNOWLEDGMENT AND ACCEPTANCE OF THESE TERMS AND CONDITIONS.

The purchase of this Product conveys to you, the Buyer, the NON-TRANSFERABLE right to use the purchased Product for Licensed Research Use (see definition below) subject to the conditions set out in this License Agreement. If you wish to use this Product for any purpose other than Licensed Research Use, you must first obtain an appropriate license (see information set out below).

This Product may not be used for any purpose other than Licensed Research Use. Your right to use this Product for Licensed Research Use is subject to the following conditions and restrictions:

1. Licensed Research Use means any use for research purposes, with the following exceptions:

i. Buyer may not sell or otherwise transfer the Product (including without limitation any material that contains the Product in whole or part) or any Related Material to any other third party (except that you may transfer the Product, including without limitation any material that contains the Product in whole or in part, or any Related Material to a bona fide collaborator or contract research person or entity), or use the Products or any Related Material to perform services for the benefit of any other person or entity;

ii. Buyer may use only the purchased amount of the Product and components of the Product, and shall use any Related Material, only for your internal research within the Field, and not for any Commercial Purposes;

iii. Buyer shall use the Product and any Related Material in compliance with all applicable laws and regulations, including without limitation applicable human health and animal welfare laws and regulations;

iv. Sigma shall provide no warranties of any kind to the Buyer (statutory or implied) concerning the Patent Rights, the Product or any Related Materials, including without limitation, as to product quality, condition, description, merchantability, fitness for a particular purpose, noninfringement of intellectual property rights or the absence of latent or other defects, and all such warranties are hereby expressly disclaimed;

v. Sigma shall expressly disclaim any warranty regarding results obtained through the use of the Product or Related Materials, including without limitation any claim of inaccurate, invalid or incomplete results;

vi. Sigma, and their directors, officers, employees and agents, shall have no liability to the Buyer, including, without limitation, for any loss of use or profits, business interruption or any consequential, incidental, special or other indirect damages of any kind, regardless of how caused and regardless of whether an action in contract, tort, strict product liability or otherwise;

vii. the Buyer shall indemnify, defend, and hold harmless Sigma and their current and former directors, officers, employees and agents, and their respective successors, heirs and assigns (the Indemnities) against any liability, damage, loss, or expense (including without limitation reasonable attorneys’ fees and expenses) incurred by or imposed upon any of the Indemnitees in connection with any claims, suits, investigations, actions, demands or judgments arising out of or related to the exercise of any rights granted to the Buyer hereunder or any breach of this License Agreement by such Buyer; and

viii. the Product and its use may be the subject of one or more issued patents and/or pending patent applications owned by Sigma and the purchase of the Product does not convey a license under any claims in the foregoing patents or patent applications directed to the Licensed Product or use, production or commercialization thereof.

For purposes of Section 1 above, the following definitions shallapply:

Commercial Purposes means (a) the practice, performance or provision of any method, process or service, or (b) the manufacture, sale, use, distribution, disposition or importing of any product, in each case (a) or (b) for consideration, e.g., a fee, or on any other commercial basis.

Field means use as a research tool for research purposes; provided, however, that notwithstanding the foregoing, the Field shall expressly exclude (a) any in vivo and ex vivo human or clinical use, including, without limitation, any administration into humans or any diagnostic or prognostic use, (b) the creation of transgenic rodent models and/or derivatives thereof (including, but not limited to, rodents’ cells and rodents’ organs) by for-profit entities, (c) any in vivo veterinary or livestock use, or non-research agricultural use, or (d) the manufacture, distribution, importation, exportation, transportation, sale, offer for sale, marketing, promotion or other exploitation or use of, or as, a testing service, therapeutic or diagnostic for humans or animals.

Related Materials means any progeny, modification or derivative of a Product.

2. Your right to use the Product will terminate immediately if you fail to comply with these terms and conditions. You shall, upon such termination of your rights, destroy all Product, Related Materials, and components thereof in your control, and notify Sigma of such in writing. For information on purchasing a license to this Product for purposes other than Licensed Research Use, contact your local Sigma sales representative, who will refer you to the proper licensing representative, or in the USA call 800-325-3010.

Sigma-Aldrich Patent Rights:

Patent applications and issued patents that entered their respective National Stage from PCT International Pub. No. WO 2014/089290

Limited Use Licenses for ioNEURONS/glut - Glutamatergic Neurons

This Product is provided by Bit Bio Ltd (Bit Bio) in partnership with Abcam Ltd (Abcam) under license from iPS Academia Japan, TET Systems GmbH, ERS Genomics Limited and Sigma-Aldrich Co. LLC.

Use of the Product is restricted to the terms contained within the individual Limited Use License Notices from each of the Licensors as set out below, and also by the general restriction that the User must only use the Product, Progeny, any Modifications of the Product and any Unmodified Derivatives of the Product in the Field.

The following Definitions apply to all Limited Use License Notices.

Field: Internal research use only. No Commercial Use is allowed.

Commercial Use: Any and all uses of the Product, Progeny, Modifications or Unmodified Derivatives thereof, by a party for monetary or other consideration and can include, but is not limited to use in:

(i) Manufacture of a Product;

(ii) Sale of a Product, Progeny, Modifications or Unmodified Derivatives thereof, whether or not such sale is limited for use in research;

(iii) Provision of a service to a third party;

​(iv) Use in any diagnostic, preventative, or therapeutic application;

(v) Use in any veterinary, livestock or agricultural application; and

​(vi) Use in later stage development of therapeutics, diagnostics, prophylactics (e.g., hit-to-lead, lead optimization).

Product: Cells which are differentiated from human iPS cells by Bit Bio Ltd., and which Bit Bio Ltd. sells, or are sold on behalf of Bit Bio Ltd. by a distributor

Progeny: Any unmodified descendant form of the Product

Modifications: Any modifications of the Product

Unmodified Derivatives: Any substances created by the User that constitute an unmodified functional subunit or product expressed by the Product

User: The person or entity who purchased the Product(s) from Abcam in partnership with Bit Bio.

iPS Academia Japan, Inc.

The Product is sold by Abcam in partnership with Bit Bio under license from iPS Academia Japan, Inc (iPS-AJ). The Product is covered by one or more claims of issued patents and pending patent applications, including: U.S. Patent Nos. 8,048,999, 8,058,065, 8,129,187 and 8,278,104 and foreign counterparts thereof, including their divisions, continuations, extensions, substitutions, and those claiming priority therefrom or those claiming the same priorities therein.

The use of this Product is strictly limited to User’s own internal research as described in the iPS-AJ User Restrictions Notice set out below:

  1. All Users may use the Product for internal research only including but not limited to screening potential drug compounds for efficacy and safety. No other right is granted to User whether expressly, by implication, by estoppel or otherwise. In particular, the purchase of the Product does not include nor carry any right or license to use, develop or otherwise exploit the Product commercially, and no rights are conveyed to User to use the Product for any other purpose other than specified in the Field.
  2. User agrees to use the Product in compliance with all applicable statutes and regulations, but not to use the Product for any administration or application to humans. Moreover, User agrees not to use the Product in human subjects for human clinical use for therapeutic, diagnostic or prophylactic purposes, or in animals for veterinary use for therapeutic, diagnostic or prophylactic purposes, including but not limited to clinical applications, cell therapy, transplantation, and/or regenerative medicine without an appropriate license.
  3. In the case that User transfers Product to a third party (provided such transfer is not contrary to the terms of other relevant limited use licenses relevant to the Product), User shall convey the User Restrictions set forth herein to such a third party.

TET Systems GmbH

This Product contains the Tetracycline controllable expression system (the "Tet Technology"). The Tet Technology IP portfolio is proprietary to TET Systems GmbH & Co. KG (''TET Systems") and comprises a series of patents including U.S. patents 8,383,364, 9,181,556, European Patents EP 1954811, 2352833 and corresponding patent claims outside these regions. The purchaser of the Product (i.e. the User) is granted an automatic license to use the Tet Technology in the Field and excludes the right to transfer or sell the Product, the Tet Technology or its component parts to third parties. Users whose research using the Product is sponsored by for-profit organizations, which shall receive ownership to any data or results stemming from the sponsored research, shall need a license agreement from TET Systems in order to use this Product.

All Users of the Product acknowledge that the Tet Technology is experimental in nature. TET Systems makes no warranties, express or implied or of any kind, and hereby disclaims any warranties, representations, or guarantees of any kind as to the Tet Technology, patents, or products.

Under the terms specified in the Limited Use License all Users of this Product that do not have a license from TET Systems will be restricted to the purchase of less than 10 units of Product per annum. If the User is purchasing more than 10 units of Product per annum, a TET license will be required from TET Systems GmbH & Co. KG - please contact Abcam.

ERS GENOMICS Limited

CRISPR Non-Exclusive License Agreement

Certain commercial entities and/or activities performed at commercial entities may require additional contract rights from ERS Genomics Limited which are not granted through the purchase of this product. For additional information please see www.ersgenomics.com.

The User (purchaser) receives a non-exclusive, non-transferable right to use the Product, Progeny, Modifications and Unmodified Derivatives for RESEARCH USE ONLY, which, subject to the exclusions below, includes use to discover and develop any product, including therapeutic products, which may then be sold to third parties, provided, however, that such products do not incorporate the Product, Progeny, Modifications, or Unmodified Derivatives.

For clarity, transfer of materials or provision of services by not for profit or academic core labs to their internal clients shall not constitute Commercial Use.

Except for the rights granted herein, any and all rights to the Product, Progeny, Modifications or Unmodified Derivatives thereof, shall remain in Bit Bio Ltd. No ownership rights are transferred.

The User shall have no right to assign the rights granted herein to third parties. The Product, Progeny, Modifications or Unmodified Derivatives thereof, must at all times remain in the possession of the User, except for a transfer to a scientific collaborator or to a service provider, to perform services, solely on behalf of the User.

ERS Genomics Limited is an intended third-party beneficiary under these Terms of Use.

Sigma-Aldrich Co. LLC

ZFN License Agreement

This Product and its use are the subject of one or more of the following patents controlled by Sangamo BioSciences, Inc.: U.S. Patent Nos. 6,534,261, 6,607,882, 6,746,838, 6,794,136, 6,824,978, 6,866,997,

6,933,113, 6,979,539, 7,013,219, 7,030,215, 7,220,719, 7,241,573, 7,241,574, 7,585,849, 7,595,376,

6,903,185, 6,479,626, US20030232410, US20090203140 and corresponding foreign patent applications and patents.

BEFORE OPENING OR USING THIS PRODUCT, PLEASE READ THE TERMS AND CONDITIONS SET FORTH IN THIS LICENSE AGREEMENT. YOUR USE OF THIS PRODUCT SHALL CONSTITUTE ACKNOWLEDGMENT AND ACCEPTANCE OF THESE TERMS AND CONDITIONS.

The purchase of this Product conveys to the User, the non-transferable right to use the purchased Product in the Field. If you wish to use this Product for any purpose other than Licensed Research Use, you must first obtain an appropriate license from Sigma-Aldrich Co. LLC